Development of a smart transformable nanotherapeutic against cancers with acquired resistance to EGFR-targeted therapies caused by MET amplification

Development of a smart transformable nanotherapeutic against cancers with acquired resistance to EGFR-targeted therapies caused by MET amplification

Related Resources

The following grant was awarded by, is supported by, is administered by or is in partnership with the Fogarty International Center at the U.S. National Institutes of Health (NIH).

Funding Fogarty Program

Emerging Global Leader

Project Information in NIH RePORTER

Development of a smart transformable nanotherapeutic against cancers with acquired resistance to EGFR-targeted therapies caused by MET amplification

Principal Institution

Khon Kaen University

Principal Investigator(s) (PI)

Mahalapbutr, Panupong

Project Contact Information

Email: panupma@kku.ac.th

Year(s) Awarded

2024-2029

Country

Thailand

Collaborators

University of California

NIH Partners

NCI

Related Global Health Research Topics

  • Cancer